Literature DB >> 6210339

Inhibition of antigen-specific T lymphocyte activation by structurally related Ir gene-controlled polymers. II. Competitive inhibition of I-E-restricted, antigen-specific T cell responses.

K L Rock, B Benacerraf.   

Abstract

Our previous studies have defined a highly specific competitive inhibition between a pair of structurally related antigens (GT and GAT) for antigen presentation by accessory cells. The present report investigates this phenomenon in a second antigenic system, which is controlled by a distinct Ir gene product. Two GL phi-specific, I-Ed-restricted, interleukin 2-producing T cell hybridomas were constructed. The antigenic fine specificity of these two hybrid clones was distinct. One hybrid reacted solely with GL phi while the second cross-reacted with GLleu and GLT. These latter two copolymers, as well as the antigen GL, were found to inhibit the GL phi response of the non-cross-reactive hybrid. The structurally related antigen G phi was not inhibitory for this clone's response. The cross-reactive GL phi hybrid could also be inhibited, but, in this case, G phi and not GL caused the inhibition. Reciprocal inhibitions could be demonstrated between these and other hybrids (e.g., GAT responsive), indicating a very high degree of specificity to the inhibition. The inhibition caused by the various copolymers was reversible by increasing the concentration of GL phi, This effect was localized to the antigen-presenting cell and not the T cell hybridoma. Functionally, this competition did not appear to be for antigen uptake or general antigen processing. These findings generalize the phenomenon of antigen competition to a second antigen system in the context of a second Ia molecule. The possible mechanisms accounting for the complex pattern of specificities in this system are discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6210339      PMCID: PMC2187519          DOI: 10.1084/jem.160.6.1864

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  21 in total

Review 1.  Interaction between antigen-presenting cells and primed T lymphocytes: an assessment of Ir gene expression in the antigen-presenting cell.

Authors:  R H Schwartz; A Yano; W E Paul
Journal:  Immunol Rev       Date:  1978       Impact factor: 12.988

2.  Complementation of H-2-linked Ir genes in the mouse.

Authors:  M E Dorf; B Benacerraf
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

3.  Establishment and characterization of BALB/c lymphoma lines with B cell properties.

Authors:  K J Kim; C Kanellopoulos-Langevin; R M Merwin; D H Sachs; R Asofsky
Journal:  J Immunol       Date:  1979-02       Impact factor: 5.422

Review 4.  A hypothesis to relate the specificity of T lymphocytes and the activity of I region-specific Ir genes in macrophages and B lymphocytes.

Authors:  B Benacerraf
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

Review 5.  The immune response genes of the major histocompatibility complex.

Authors:  B Benacerraf; R N Germain
Journal:  Immunol Rev       Date:  1978       Impact factor: 12.988

6.  Genetic control of the immune response to the radom linear terpolymer of L-glutamic acid, L-lysine and L-leucine (GLleu) by complementing Ir genes.

Authors:  M E Dorf; M B Twigg; B Benacerraf
Journal:  Eur J Immunol       Date:  1976-08       Impact factor: 5.532

Review 7.  Determinant selection and macrophage function in genetic control of the immune response.

Authors:  A S Rosenthal
Journal:  Immunol Rev       Date:  1978       Impact factor: 12.988

8.  The role of Ia molecules in the activation of T lymphocytes. III. Antigen-specific, Ia-restricted, interleukin 2-producing T cell hybridomas with detectable affinity for the restricting I-A molecule.

Authors:  K L Rock; B Benacerraf
Journal:  J Exp Med       Date:  1983-01-01       Impact factor: 14.307

9.  Inclusion group systems and cis-trans effects in responses controlled by the two complementing Ir-GLphi genes.

Authors:  M E Dorf; P H Maurer; F Merryman; B Benacerraf
Journal:  J Exp Med       Date:  1976-04-01       Impact factor: 14.307

10.  Function of macrophages in antigen recognition by guinea pig T lymphocytes. I. Requirement for histocompatible macrophages and lymphocytes.

Authors:  A S Rosenthal; E M Shevach
Journal:  J Exp Med       Date:  1973-11-01       Impact factor: 14.307

View more
  7 in total

1.  Antigenic competition between dengue and Coxsackie viruses for presentation to B cells by macrophages.

Authors:  N Rizvi; U C Chaturvedi; A Mathur
Journal:  Int J Exp Pathol       Date:  1990-12       Impact factor: 1.925

Review 2.  Virus-immune T cells and the major histocompatibility complex: evolution of some basic concepts over the past two years.

Authors:  P C Doherty
Journal:  Experientia       Date:  1986-09-15

3.  Antigenic competition at the level of peptide-Ia binding.

Authors:  B P Babbitt; G Matsueda; E Haber; E R Unanue; P M Allen
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

4.  Significance and biological function of class II MHC molecules. Rous-Whipple Award lecture 1985.

Authors:  B Benacerraf
Journal:  Am J Pathol       Date:  1985-09       Impact factor: 4.307

5.  Phospholipase treatment of accessory cells that have been exposed to antigen selectively inhibits antigen-specific Ia-restricted, but not allospecific, stimulation of T lymphocytes.

Authors:  L D Falo; B Benacerraf; K L Rock
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

6.  Analysis of antigen presentation by metabolically inactive accessory cells and their isolated membranes.

Authors:  L D Falo; K Sullivan; B Benacerraf; M F Mescher; K L Rock
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

7.  Characterization of antigen association with accessory cells: specific removal of processed antigens from the cell surface by phospholipases.

Authors:  L D Falo; S I Haber; S Herrmann; B Benacerraf; K L Rock
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.